nodes	percent_of_prediction	percent_of_DWPC	metapath
Nepafenac—PTGS2—autistic disorder	0.975	1	CbGaD
Nepafenac—Ketorolac—PTGS2—autistic disorder	0.00105	0.151	CrCbGaD
Nepafenac—Bromfenac—PTGS2—autistic disorder	0.00101	0.145	CrCbGaD
Nepafenac—PTGS2—C-MYB transcription factor network—SND1—autistic disorder	0.000864	0.0494	CbGpPWpGaD
Nepafenac—Tiaprofenic acid—PTGS2—autistic disorder	0.000859	0.123	CrCbGaD
Nepafenac—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—autistic disorder	0.000805	0.046	CbGpPWpGaD
Nepafenac—Magnesium salicylate—PTGS2—autistic disorder	0.000799	0.115	CrCbGaD
Nepafenac—Fenbufen—PTGS2—autistic disorder	0.000782	0.112	CrCbGaD
Nepafenac—Salsalate—PTGS2—autistic disorder	0.000679	0.0974	CrCbGaD
Nepafenac—Fenoprofen—PTGS2—autistic disorder	0.000561	0.0805	CrCbGaD
Nepafenac—Mefenamic acid—PTGS2—autistic disorder	0.000521	0.0747	CrCbGaD
Nepafenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—BTD—autistic disorder	0.000482	0.0276	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—EGR2—autistic disorder	0.000455	0.026	CbGpPWpGaD
Nepafenac—Diclofenac—PTGS2—autistic disorder	0.000374	0.0537	CrCbGaD
Nepafenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—EIF4E—autistic disorder	0.000373	0.0213	CbGpPWpGaD
Nepafenac—PTGS1—Prostaglandin Synthesis and Regulation—PRL—autistic disorder	0.000348	0.0199	CbGpPWpGaD
Nepafenac—Ketoprofen—PTGS2—autistic disorder	0.000331	0.0475	CrCbGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—NF1—autistic disorder	0.00032	0.0183	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—XDH—autistic disorder	0.00031	0.0177	CbGpPWpGaD
Nepafenac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—autistic disorder	0.000303	0.0173	CbGpPWpGaD
Nepafenac—PTGS1—Prostaglandin Synthesis and Regulation—PLA2G4A—autistic disorder	0.000292	0.0167	CbGpPWpGaD
Nepafenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC19A1—autistic disorder	0.000284	0.0162	CbGpPWpGaD
Nepafenac—PTGS2—Prostaglandin Synthesis and Regulation—PRL—autistic disorder	0.000277	0.0158	CbGpPWpGaD
Nepafenac—PTGS1—Phase 1 - Functionalization of compounds—MAOB—autistic disorder	0.000264	0.0151	CbGpPWpGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—BCL2—autistic disorder	0.00025	0.0143	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—XDH—autistic disorder	0.000246	0.0141	CbGpPWpGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—PTGS2—autistic disorder	0.000237	0.0136	CbGpPWpGaD
Nepafenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—TCN2—autistic disorder	0.000236	0.0135	CbGpPWpGaD
Nepafenac—PTGS2—Prostaglandin Synthesis and Regulation—PLA2G4A—autistic disorder	0.000232	0.0133	CbGpPWpGaD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—autistic disorder	0.000232	0.0132	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—ADA—autistic disorder	0.000231	0.0132	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—GSTM5—autistic disorder	0.000227	0.013	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL5—autistic disorder	0.000211	0.012	CbGpPWpGaD
Nepafenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—PLA2G4A—autistic disorder	0.000205	0.0117	CbGpPWpGaD
Nepafenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—MEF2C—autistic disorder	0.000199	0.0114	CbGpPWpGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—BCL2—autistic disorder	0.000198	0.0113	CbGpPWpGaD
Nepafenac—PTGS1—Eicosanoid Synthesis—PTGS2—autistic disorder	0.000197	0.0113	CbGpPWpGaD
Nepafenac—PTGS1—Arachidonic acid metabolism—PLA2G4A—autistic disorder	0.000194	0.0111	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—MIF—autistic disorder	0.000191	0.0109	CbGpPWpGaD
Nepafenac—PTGS1—Arachidonic acid metabolism—GPX1—autistic disorder	0.000186	0.0106	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—NTF3—autistic disorder	0.000166	0.00947	CbGpPWpGaD
Nepafenac—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—autistic disorder	0.000165	0.00941	CbGpPWpGaD
Nepafenac—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—autistic disorder	0.00016	0.00914	CbGpPWpGaD
Nepafenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—autistic disorder	0.000157	0.00898	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—AQP4—autistic disorder	0.000157	0.00897	CbGpPWpGaD
Nepafenac—PTGS2—Arachidonic acid metabolism—PLA2G4A—autistic disorder	0.000154	0.00881	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—autistic disorder	0.00015	0.00857	CbGpPWpGaD
Nepafenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—autistic disorder	0.000149	0.00849	CbGpPWpGaD
Nepafenac—PTGS1—Phase 1 - Functionalization of compounds—MAOA—autistic disorder	0.000148	0.00844	CbGpPWpGaD
Nepafenac—PTGS2—Arachidonic acid metabolism—GPX1—autistic disorder	0.000148	0.00843	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—MAOB—autistic disorder	0.00014	0.00802	CbGpPWpGaD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—autistic disorder	0.00014	0.00801	CbGpPWpGaD
Nepafenac—PTGS2—S1P1 pathway—MAPK1—autistic disorder	0.000134	0.00763	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—CAT—autistic disorder	0.000131	0.00747	CbGpPWpGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—IL6—autistic disorder	0.000129	0.00739	CbGpPWpGaD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—autistic disorder	0.000124	0.00712	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—GPX1—autistic disorder	0.000118	0.00676	CbGpPWpGaD
Nepafenac—PTGS1—Arachidonic acid metabolism—PTGS2—autistic disorder	0.000109	0.00625	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—MTHFR—autistic disorder	0.000109	0.00624	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—DHCR7—autistic disorder	0.000108	0.00618	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—CAT—autistic disorder	0.000104	0.00593	CbGpPWpGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—IL6—autistic disorder	0.000103	0.00587	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—GSTM1—autistic disorder	0.000102	0.00582	CbGpPWpGaD
Nepafenac—PTGS1—Phase 1 - Functionalization of compounds—POMC—autistic disorder	9.61e-05	0.00549	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—GPX1—autistic disorder	9.39e-05	0.00537	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—autistic disorder	9.06e-05	0.00518	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—GJA1—autistic disorder	8.94e-05	0.00511	CbGpPWpGaD
Nepafenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—autistic disorder	8.74e-05	0.005	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—MTHFR—autistic disorder	8.66e-05	0.00495	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—DHCR7—autistic disorder	8.58e-05	0.00491	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—CYP19A1—autistic disorder	8.49e-05	0.00486	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—autistic disorder	8.48e-05	0.00485	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—BDNF—autistic disorder	8.12e-05	0.00464	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—autistic disorder	8.05e-05	0.0046	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—SERPINE1—autistic disorder	7.97e-05	0.00456	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—COMT—autistic disorder	7.9e-05	0.00451	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—GSTP1—autistic disorder	7.86e-05	0.00449	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—MAOA—autistic disorder	7.84e-05	0.00448	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL4—autistic disorder	7.54e-05	0.00431	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—IFNG—autistic disorder	7.26e-05	0.00415	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—GSTM1—autistic disorder	7.22e-05	0.00413	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—PTGS2—autistic disorder	6.96e-05	0.00398	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—NPAS2—autistic disorder	6.84e-05	0.00391	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—INPP1—autistic disorder	6.76e-05	0.00386	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ACADSB—autistic disorder	6.76e-05	0.00386	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—autistic disorder	6.58e-05	0.00376	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—LEP—autistic disorder	6.38e-05	0.00365	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—SERPINE1—autistic disorder	6.33e-05	0.00362	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—BCL2—autistic disorder	6.04e-05	0.00345	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—AR—autistic disorder	6.03e-05	0.00345	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—BTD—autistic disorder	6.02e-05	0.00344	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—NOS2—autistic disorder	5.94e-05	0.0034	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IFNG—autistic disorder	5.76e-05	0.00329	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—RORA—autistic disorder	5.75e-05	0.00328	CbGpPWpGaD
Nepafenac—PTGS2—Disease—BTD—autistic disorder	5.71e-05	0.00326	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—autistic disorder	5.52e-05	0.00316	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—NPAS2—autistic disorder	5.43e-05	0.0031	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—INPP1—autistic disorder	5.36e-05	0.00307	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ACADSB—autistic disorder	5.36e-05	0.00307	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—HRAS—autistic disorder	5.28e-05	0.00302	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—autistic disorder	5.27e-05	0.00301	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—TDO2—autistic disorder	5.12e-05	0.00293	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—POMC—autistic disorder	5.11e-05	0.00292	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—DHCR7—autistic disorder	4.82e-05	0.00275	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—BTD—autistic disorder	4.78e-05	0.00273	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—EXT1—autistic disorder	4.56e-05	0.00261	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLC6A8—autistic disorder	4.56e-05	0.00261	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—RORA—autistic disorder	4.56e-05	0.00261	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IFNG—autistic disorder	4.56e-05	0.00261	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—DAO—autistic disorder	4.35e-05	0.00249	CbGpPWpGaD
Nepafenac—PTGS2—Disease—EXT1—autistic disorder	4.33e-05	0.00247	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—UPB1—autistic disorder	4.17e-05	0.00239	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—TDO2—autistic disorder	4.07e-05	0.00232	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL2—autistic disorder	4.05e-05	0.00232	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—APC—autistic disorder	3.92e-05	0.00224	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GSTM5—autistic disorder	3.88e-05	0.00222	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ASMT—autistic disorder	3.88e-05	0.00222	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—autistic disorder	3.87e-05	0.00221	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—DHCR7—autistic disorder	3.82e-05	0.00219	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—IL6—autistic disorder	3.79e-05	0.00217	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLC25A12—autistic disorder	3.65e-05	0.00209	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—EXT1—autistic disorder	3.62e-05	0.00207	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC6A8—autistic disorder	3.62e-05	0.00207	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—autistic disorder	3.58e-05	0.00205	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLC19A1—autistic disorder	3.55e-05	0.00203	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SLC25A12—autistic disorder	3.46e-05	0.00198	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—DAO—autistic disorder	3.46e-05	0.00198	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SLC19A1—autistic disorder	3.36e-05	0.00192	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—UPB1—autistic disorder	3.31e-05	0.00189	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—HRAS—autistic disorder	3.26e-05	0.00187	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	3.26e-05	0.00186	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ADSL—autistic disorder	3.16e-05	0.00181	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—autistic disorder	3.13e-05	0.00179	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—XDH—autistic disorder	3.1e-05	0.00177	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—MAPK1—autistic disorder	3.1e-05	0.00177	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTM5—autistic disorder	3.08e-05	0.00176	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ASMT—autistic disorder	3.08e-05	0.00176	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—STX1A—autistic disorder	3.05e-05	0.00174	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NPAS2—autistic disorder	3.05e-05	0.00174	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IL6—autistic disorder	3.01e-05	0.00172	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—TCN2—autistic disorder	2.94e-05	0.00168	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC25A12—autistic disorder	2.9e-05	0.00166	CbGpPWpGaD
Nepafenac—PTGS2—Disease—STX1A—autistic disorder	2.89e-05	0.00165	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC19A1—autistic disorder	2.82e-05	0.00161	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ADA—autistic disorder	2.81e-05	0.0016	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TCN2—autistic disorder	2.79e-05	0.00159	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	2.77e-05	0.00159	CbGpPWpGaD
Nepafenac—PTGS2—Disease—WNT2—autistic disorder	2.7e-05	0.00154	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	2.66e-05	0.00152	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—autistic disorder	2.59e-05	0.00148	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	2.59e-05	0.00148	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—RORA—autistic disorder	2.56e-05	0.00146	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ADSL—autistic disorder	2.51e-05	0.00144	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—XDH—autistic disorder	2.46e-05	0.00141	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NPAS2—autistic disorder	2.42e-05	0.00138	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—STX1A—autistic disorder	2.42e-05	0.00138	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—MAOB—autistic disorder	2.4e-05	0.00137	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL6—autistic disorder	2.38e-05	0.00136	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—TCN2—autistic disorder	2.34e-05	0.00133	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—APOE—autistic disorder	2.28e-05	0.0013	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—TPH2—autistic disorder	2.23e-05	0.00127	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RPL10—autistic disorder	2.23e-05	0.00127	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ADA—autistic disorder	2.23e-05	0.00127	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	2.2e-05	0.00126	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—DPYD—autistic disorder	2.19e-05	0.00125	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	2.11e-05	0.00121	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—autistic disorder	2.11e-05	0.0012	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	2.06e-05	0.00118	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CACNA1C—autistic disorder	2.04e-05	0.00117	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—RORA—autistic disorder	2.03e-05	0.00116	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—POMC—autistic disorder	1.96e-05	0.00112	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—MAOB—autistic disorder	1.9e-05	0.00109	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—DHFR—autistic disorder	1.85e-05	0.00106	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—APOE—autistic disorder	1.81e-05	0.00104	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—TPH2—autistic disorder	1.77e-05	0.00101	CbGpPWpGaD
Nepafenac—PTGS2—Disease—DHFR—autistic disorder	1.76e-05	0.00101	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—DPYD—autistic disorder	1.74e-05	0.000995	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	1.63e-05	0.000935	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CACNA1C—autistic disorder	1.62e-05	0.000925	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CALCA—autistic disorder	1.58e-05	0.000904	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.56e-05	0.000894	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—POMC—autistic disorder	1.56e-05	0.00089	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—DHFR—autistic disorder	1.47e-05	0.000842	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP19A1—autistic disorder	1.45e-05	0.00083	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PRL—autistic disorder	1.4e-05	0.000799	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.36e-05	0.00078	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—COMT—autistic disorder	1.35e-05	0.000772	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GSTP1—autistic disorder	1.34e-05	0.000768	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—MAOA—autistic disorder	1.34e-05	0.000767	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CAT—autistic disorder	1.31e-05	0.000748	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PLA2G4A—autistic disorder	1.24e-05	0.000706	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GSTM1—autistic disorder	1.24e-05	0.000706	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GPX1—autistic disorder	1.18e-05	0.000676	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP19A1—autistic disorder	1.15e-05	0.000659	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—MTHFR—autistic disorder	1.09e-05	0.000624	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.08e-05	0.000619	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—COMT—autistic disorder	1.07e-05	0.000613	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTP1—autistic disorder	1.07e-05	0.00061	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—MAOA—autistic disorder	1.06e-05	0.000609	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CAT—autistic disorder	1.04e-05	0.000594	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MTHFR—autistic disorder	1.03e-05	0.000592	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HLA-A—autistic disorder	1.03e-05	0.00059	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOE—autistic disorder	1.02e-05	0.000581	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TSC2—autistic disorder	9.84e-06	0.000563	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTM1—autistic disorder	9.81e-06	0.000561	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PLA2G4A—autistic disorder	9.81e-06	0.000561	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOE—autistic disorder	9.63e-06	0.000551	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GPX1—autistic disorder	9.39e-06	0.000537	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PIK3CG—autistic disorder	9.17e-06	0.000524	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOS2—autistic disorder	8.98e-06	0.000513	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—POMC—autistic disorder	8.73e-06	0.000499	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APC—autistic disorder	8.69e-06	0.000497	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—MTHFR—autistic disorder	8.67e-06	0.000495	CbGpPWpGaD
Nepafenac—PTGS2—Disease—EGF—autistic disorder	8.59e-06	0.000491	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOE—autistic disorder	8.07e-06	0.000461	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SERPINE1—autistic disorder	7.56e-06	0.000432	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PIK3CG—autistic disorder	7.28e-06	0.000416	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PTGS2—autistic disorder	6.96e-06	0.000398	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—POMC—autistic disorder	6.93e-06	0.000396	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PTEN—autistic disorder	6.07e-06	0.000347	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PTEN—autistic disorder	5.76e-06	0.000329	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PTEN—autistic disorder	4.82e-06	0.000276	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MAPK1—autistic disorder	4.68e-06	0.000268	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HRAS—autistic disorder	3.76e-06	0.000215	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IL6—autistic disorder	3.6e-06	0.000206	CbGpPWpGaD
